Tüting T - Search Results

1

Biolistic DNA vaccination against melanoma.

Steitz J, Tüting T. Steitz J, et al. Among authors: tuting t. Methods Mol Biol. 2013;940:317-37. doi: 10.1007/978-1-62703-110-3_24. Methods Mol Biol. 2013. PMID: 23104352

2

Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination.

Steitz J, Tormo D, Schweichel D, Tüting T. Steitz J, et al. Among authors: tuting t. Cancer Gene Ther. 2006 Mar;13(3):318-25. doi: 10.1038/sj.cgt.7700894. Cancer Gene Ther. 2006. PMID: 16151477

3

Altered intracellular sorting signals do not influence the efficacy of genetic melanoma vaccines incorporating helper determinants in mice.

Brück J, Steitz J, Strand D, Tüting T. Brück J, et al. Among authors: tuting t. J Gene Med. 2005 May;7(5):613-20. doi: 10.1002/jgm.702. J Gene Med. 2005. PMID: 15580620

4

Peripheral CD8+ T cell tolerance against melanocytic self-antigens in the skin is regulated in two steps by CD4+ T cells and local inflammation: implications for the pathophysiology of vitiligo.

Steitz J, Brück J, Lenz J, Büchs S, Tüting T. Steitz J, et al. Among authors: tuting t. J Invest Dermatol. 2005 Jan;124(1):144-50. doi: 10.1111/j.0022-202X.2004.23538.x. J Invest Dermatol. 2005. PMID: 15654968 Free article.

5

Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo.

Steitz J, Wenzel J, Gaffal E, Tüting T. Steitz J, et al. Among authors: tuting t. Eur J Cell Biol. 2004 Dec;83(11-12):797-803. doi: 10.1078/0171-9335-00423. Eur J Cell Biol. 2004. PMID: 15679123 Review.

6

Evaluation of genetic melanoma vaccines in cdk4-mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skin.

Steitz J, Büchs S, Tormo D, Ferrer A, Wenzel J, Huber C, Wölfel T, Barbacid M, Malumbres M, Tüting T. Steitz J, et al. Among authors: tuting t. Int J Cancer. 2006 Jan 15;118(2):373-80. doi: 10.1002/ijc.21349. Int J Cancer. 2006. PMID: 16049960

7

Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2.

Steitz J, Britten CM, Wölfel T, Tüting T. Steitz J, et al. Among authors: tuting t. Cancer Immunol Immunother. 2006 Mar;55(3):246-53. doi: 10.1007/s00262-005-0042-5. Epub 2005 Aug 13. Cancer Immunol Immunother. 2006. PMID: 16133114 Free PMC article.

8

Evaluation of DNA vaccination with recombinant adenoviruses using bioluminescence imaging of antigen expression: impact of application routes and delivery with dendritic cells.

Schweichel D, Steitz J, Tormo D, Gaffal E, Ferrer A, Büchs S, Speuser P, Limmer A, Tüting T. Schweichel D, et al. Among authors: tuting t. J Gene Med. 2006 Oct;8(10):1243-50. doi: 10.1002/jgm.952. J Gene Med. 2006. PMID: 16892456

9

Comparative evaluation of CD8+CTL responses following gene gun immunization targeting the skin with intracutaneous injection of antigen-transduced dendritic cells.

Gaffal E, Schweichel D, Tormo D, Steitz J, Lenz J, Basner-Tschakarjan E, Limmer A, Tüting T. Gaffal E, et al. Among authors: tuting t. Eur J Cell Biol. 2007 Dec;86(11-12):817-26. doi: 10.1016/j.ejcb.2006.07.002. Epub 2006 Aug 22. Eur J Cell Biol. 2007. PMID: 16928407

10

Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation.

Bald T, Landsberg J, Lopez-Ramos D, Renn M, Glodde N, Jansen P, Gaffal E, Steitz J, Tolba R, Kalinke U, Limmer A, Jönsson G, Hölzel M, Tüting T. Bald T, et al. Among authors: tuting t. Cancer Discov. 2014 Jun;4(6):674-87. doi: 10.1158/2159-8290.CD-13-0458. Epub 2014 Mar 3. Cancer Discov. 2014. PMID: 24589924

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters